Stanford MS Epidemiology and Clinical Research

What is the Stanford MS Epidemiology and Clinical Research?

The Stanford MS Epidemiology and Clinical Research is a 45-unit, full-time campus degree planned across about 21 months. Its official curriculum provides the programme-specific scope used for this decision. The conservative full-programme plan is INR 2.29 crore, using 2026-27 tuition and Stanford’s current graduate living budget.

For Autumn 2027, the academic path begins with Design and Conduct of Clinical and Epidemiologic Studies and Advanced Epidemiologic Methods, then moves into Introduction to Probability and Statistics and Intermediate Biostatistics. Applications follow the programme’s published 2027 timetable; Stanford has not yet published 2027-28 tuition, so this page retains the latest 2026-27 rates and labels the estimate.

The sequence from Design and Conduct of Clinical and Epidemiologic Studies through Advanced Epidemiologic Methods establishes epidemiologic design and biostatistics. Introduction to Probability and Statistics then tests causal inference, while Intermediate Biostatistics gives the applicant a route into clinical research. That progression, not Stanford’s name alone, is the academic reason to choose this programme.

A comparison with a neighbouring degree should begin at Design and Conduct of Clinical and Epidemiologic Studies, not at the university label. In MS Epidemiology and Clinical Research, that component establishes epidemiologic design before Advanced Epidemiologic Methods develops biostatistics. The sequence is useful for epidemiologist work only when the second component adds a capability that the applicant cannot already demonstrate.

The later curriculum changes the decision again. HRP 259 links the programme to biostatistical analyst evidence, while HRP 261 serves the different problem of real-world evidence researcher preparation. An applicant who needs neither route may be paying for breadth that does not advance the intended work.

How much does the Stanford MS Epidemiology and Clinical Research cost for an Indian student?

The full planning case is USD 238,548, about INR 2.29 crore. It combines the latest published or schedule-derived tuition and fees, Stanford’s graduate living categories for 21 months, the application fee, SEVIS and the F-1 visa fee, before flights and a housing deposit.

The table treats the SEVIS and visa charges as separate payments. It does not add a second visa-maintenance total because the complete living plan already covers the study period. Converted at USD 1 = INR 95.98, derived from ECB reference rates dated 28 September 2026.

Stanford requires international graduate students to submit a financial guarantee before the university can issue an I-20.Stanford international graduate admission

The living line starts from Stanford’s published annual graduate categories. Those figures include housing and meals, books and supplies, transport and personal costs. The 21-month multiplication is a planning assumption, so a shorter completion pattern or different housing choice changes the total.

The tuition line is a transparent calculation of 45 credits from the current school-specific 2026-27 tuition basis. It is not an invoice. Programme fees, term load and future board decisions can change what Stanford bills.

Flights, exchange spreads, a refundable housing deposit and personal contingency remain outside the table. They vary too much to attach one official amount to every applicant, but they still need cash in the funding plan before departure.

A scholarship should reduce the plan only after it appears in a written award. Campus employment is limited, competitive and dependent on authorisation, so it is not a sound way to close a known tuition gap at the application stage.

The estimate isn’t an invoice, doesn’t cap individual spending and can’t replace the payment terms in an Stanford offer. It won’t predict actual housing costs and shouldn’t be treated as a scholarship assumption. It is a common comparison case that keeps the main assumptions visible before an applicant commits.

The institution identity is independently recorded by the Research Organization Registry. That confirms the provider behind the bill, while the offer and student account remain the controlling sources for the amount and due dates.

Can an Indian applicant meet Stanford MS Epidemiology and Clinical Research entry rules?

The first check uses the school’s official admission route. It requires an accepted bachelor’s degree or an international equivalent, with quantitative and health-research preparation and does not publish a numeric minimum GPA for this programme. Subject preparation, English evidence and every listed document remain separate checks.

The 2027 testing position for MS Epidemiology and Clinical Research is explicit: GRE General optional. That rule belongs to this programme and cycle; a different Stanford department can use a different policy.

Readiness for MS Epidemiology and Clinical Research can be mapped to the curriculum. Prior work should make epidemiologic design visible before Design and Conduct of Clinical and Epidemiologic Studies, show a base for biostatistics before Advanced Epidemiologic Methods, and explain why graduate depth in causal inference is still needed.

For Design and Conduct of Clinical and Epidemiologic Studies, the admissions file should name prior work in epidemiologic design and preserve enough detail to show its level. A transcript title alone can hide whether the applicant solved, built or evaluated anything relevant to epidemiologist preparation.

Readiness for Advanced Epidemiologic Methods is a separate judgement. Evidence in biostatistics should identify the input, method and result, then explain what remained unresolved. That shows whether graduate work is the next step without claiming that professional experience substitutes for academic preparation.

The sharpest subject test sits between HRP 259 and HRP 261. Someone prepared for causal inference but not clinical research should verify that the approved plan leaves enough room to repair the second gap. Stanford’s flexible electives do not erase prerequisites for an advanced class.

A useful statement for MS Epidemiology and Clinical Research therefore connects HRP 225 to HRP 259, then explains why the culminating work is necessary for the intended biostatistical analyst direction. Repeating Stanford’s description would not prove that progression.

HRP 225 positions epidemiologic design as preparation for epidemiologist work. Before HRP 225, the file should show epidemiologic design in a completed problem, not only in a module name. That earlier epidemiologic design result needs enough method detail for a epidemiologist reviewer to judge its level. An unresolved epidemiologic design limitation is a credible reason to choose HRP 225. A mature epidemiologic design portfolio instead makes biostatistics the more useful comparison. Missing epidemiologic design foundations would make the pace of HRP 225 a risk rather than a remedy. A recommendation for epidemiologist preparation can identify where the applicant’s epidemiologic design reasoning stops. The statement can then explain which HRP 225 method should extend that reasoning. Evidence for epidemiologist readiness should keep the assumptions behind the prior epidemiologic design result. If those assumptions are absent, HRP 225 cannot be justified by a polished output alone. The alternative biostatistics route should be costed whenever it better matches the unresolved problem. That epidemiologic design versus biostatistics decision is more useful than a general claim about Stanford. For epidemiologist goals, HRP 225 therefore needs a named input, method and expected improvement. The admission case becomes weaker when epidemiologic design is asserted but never demonstrated. It becomes coherent when HRP 225, epidemiologic design and the epidemiologist objective form one sequence. Preparation for Design and Conduct (HRP 225) of Clinical and Epidemiologic Studies can be checked against the applicant’s record in statistics, biological or health science, research methods and a clinical question. The admission value of Design and Conduct (HRP 225) of Clinical and Epidemiologic Studies lies in showing why epidemiologic design needs graduate extension for epidemiologic methods, biostatistics and clinical research design. A credible starting point for Design and Conduct (HRP 225) of Clinical and Epidemiologic Studies should also connect the earlier epidemiologic design result to the later biostatistics requirement. That chain makes Design and Conduct (HRP 225) of Clinical and Epidemiologic Studies a preparation claim for epidemiologist, not a general statement of interest.

Three checks that can block a MS Epidemiology and Clinical Research application

1. No published GPA number is not an admission promise

   Stanford does not state a numeric minimum for this programme. That does not make academic performance irrelevant; the school can still compare grades, subject depth and the strength of the complete application.

2. The degree title cannot prove prerequisites

   A broad Indian degree title may hide whether epidemiologic design and biostatistics were studied at the expected depth. Syllabi or official course descriptions can make that preparation visible when transcript titles do not.

3. English rules can be degree-specific

   The working reference is TOEFL 4.5 or IELTS 7 unless an exemption applies. Stanford says individual programmes may set higher rules or restrict test formats, so the exact degree page controls.

How should an Indian applicant apply for Stanford MS Epidemiology and Clinical Research?

The application follows the official School of Medicine route for the exact campus programme. The current Autumn 2027 status is 2 February 2027 for Autumn 2027. The planning timeline allows 75 days after an offer for funding evidence, I-20 work, SEVIS payment and the visa process.

Select the exact in-person degree, upload the academic and programme documents, pay the international application fee, monitor My Stanford, clear every offer condition, submit the financial guarantee and then complete the I-20 and F-1 steps.

The allowances are Nbyula planning estimates, not processing times published by Stanford University.

Build the file around Design and Conduct of Clinical and Epidemiologic Studies and Advanced Epidemiologic Methods, not around a generic Stanford statement. Use earlier coursework or employment to show readiness, then identify the gap that the published curriculum is meant to close.

The official status is 2 February 2027 for Autumn 2027. A priority date and a final closure serve different purposes, and a published academic deadline is separate from the time needed for the I-20 and visa process.

After admission, read the offer and My Stanford task list line by line. Financial guarantee, final transcripts, immunisation records and I-20 processing can each continue after the academic decision and can each delay enrolment if ignored.

For F-1 planning, check the SEVIS I-901 step and the US visa fee page directly. Fee payment does not guarantee a visa, and a programme offer does not replace consular review.

What jobs can follow Stanford MS Epidemiology and Clinical Research?

The course structure supports directions such as epidemiologist, clinical research scientist, biostatistical analyst and real-world work sample researcher. Stanford marks the degree STEM-OPT eligible, but the OPT framework is work authorisation rather than a placement or sponsorship guarantee. Each direction still needs role-specific, inspectable work samples.

These are curriculum-linked directions for MS Epidemiology and Clinical Research, not a measured probability of employment, salary, sponsorship or promotion. Stanford publishes no exact-programme placement rate here unless a row states a named cohort and denominator.

A epidemiologist portfolio can draw most directly on HRP 225, whereas clinical research scientist evidence is more likely to depend on HRP 226. HRP 259 may support a biostatistical analyst direction and HRP 261 a real-world evidence researcher direction. These are evidence routes, not four promised jobs.

Work from Design and Conduct of Clinical and Epidemiologic Studies can support a epidemiologist application when it preserves the problem, assumptions, method and failed alternatives. The same output is weak evidence for clinical research scientist work unless Advanced Epidemiologic Methods adds the different biostatistics judgement that role requires.

For biostatistical analyst work, Introduction to Probability and Statistics matters because it can turn causal inference into an inspectable result. The hiring value comes from explaining that result and its limitations, not from listing Introduction to Probability and Statistics on a transcript.

The real-world evidence researcher direction is more dependent on Intermediate Biostatistics and clinical research. If the candidate’s approved electives cannot deepen that pair, the course may still be academically strong but poorly aligned with the stated role.

None of these four directions changes the immigration test. OPT depends on the degree classification, timely authorisation and qualifying work, while any STEM extension also depends on the employer and reporting rules. MS Epidemiology and Clinical Research does not make sponsorship automatic.

HRP 226 can translate biostatistics into evidence for a clinical research scientist application. The strongest HRP 226 artefact would record how a biostatistics decision was made and revised. A clinical research scientist reviewer needs the failed alternative as well as the successful biostatistics result. Without that reasoning, listing HRP 226 proves attendance rather than biostatistics capability. The candidate should separate individual biostatistics contributions from any team output in HRP 226. Constraints attached to the HRP 226 task also matter because clinical research scientist work rarely begins with clean inputs. Where confidentiality limits the HRP 226 submission, a public biostatistics demonstration may be necessary. That extra demonstration should be planned while the clinical research scientist problem is still fresh. For a biostatistical analyst direction, causal inference may produce more relevant evidence than HRP 226. The clinical research scientist choice should therefore compare biostatistics with causal inference, not collect both automatically. A useful HRP 226 result explains uncertainty in language a clinical research scientist audience can test. It also shows how the applicant would transfer biostatistics beyond the classroom task. Employer demand and work authorisation remain separate from the HRP 226 assessment. Neither the course nor a strong biostatistics artefact guarantees a clinical research scientist offer. Their value is a clearer, inspectable case for the chosen clinical research scientist direction. After Advanced Epidemiologic Methods, a useful portfolio should make one biostatistics judgement inspectable to a clinical research scientist audience. The outcome case for Advanced Epidemiologic Methods is stronger when the programme’s culminating work gives that biostatistics judgement a larger purpose. Earlier biostatistics evidence can then be compared with the new Advanced Epidemiologic Methods method and its clinical research scientist use. This outcome reading separates the clinical research scientist use of Advanced Epidemiologic Methods from the different biostatistical analyst path.

Who is Stanford MS Epidemiology and Clinical Research for, and who should avoid it?

A strong fit already has preparation in epidemiologic design and biostatistics, wants assessed evidence in causal inference and can fund INR 2.29 crore without promised employment. A weak fit needs foundational repair, wants a different academic centre or depends on uncertain US earnings to make the course affordable.

The practical fit test is whether epidemiologic design and biostatistics are foundations rather than missing prerequisites. Someone already able to show advanced results across causal inference and clinical research should compare a narrower route before paying for overlap.

A strong MS Epidemiology and Clinical Research profile can already explain epidemiologic design through a real result, yet still needs Design and Conduct of Clinical and Epidemiologic Studies for graduate depth. A weak profile hopes the course will teach the undergraduate foundation from the beginning.

For a candidate moving towards clinical research scientist, Advanced Epidemiologic Methods should close a named gap in biostatistics. If the applicant has already produced advanced work in that area, the better use of tuition may be a programme centred on causal inference or another specialism.

The biostatistical analyst case depends on access to Introduction to Probability and Statistics and a credible way to retain the assessed work. Where confidentiality removes every output, the candidate needs another route to demonstrate causal inference after graduation.

Someone targeting real-world evidence researcher should read the rules around Intermediate Biostatistics before accepting an offer. Course availability, prerequisites and timetable conflicts can matter more than a broad list of electives when clinical research is the reason for enrolling.

Cost fit is independent of subject fit. Even an excellent match across HRP 225, HRP 226, HRP 259 and HRP 261 is a poor decision if the applicant needs a guaranteed scholarship, campus job or US salary to make the published full-programme budget viable.

Fit around HRP 259 depends on the distance between current causal inference ability and a biostatistical analyst target. A candidate new to causal inference should not assume HRP 259 will rebuild every prerequisite at graduate pace. A candidate already advanced in causal inference needs HRP 259 to add a distinct biostatistical analyst method. The planned HRP 259 output should expose data, constraints and uncertainty around that causal inference method. A redacted or reproducible version matters when biostatistical analyst evidence cannot remain confidential. If HRP 259 cannot yield inspectable causal inference work, the portfolio plan needs another route. The competing route is clinical research, especially for applicants leaning toward real-world evidence researcher. Units assigned to HRP 259 are hard to defend when clinical research closes the more important gap. The full cost makes this causal inference versus clinical research trade-off material. Academic curiosity about HRP 259 is not by itself a fit argument for biostatistical analyst preparation. The fit argument must name the causal inference deficit and the standard used to judge improvement. It should also state why a narrower biostatistical analyst route cannot resolve the same deficit. That comparison protects the plan from overlapping causal inference and clinical research electives. For biostatistical analyst ambitions, every HRP 259 unit should support an identifiable capability test. Otherwise the candidate may prefer a programme built more directly around real-world evidence researcher needs. For fit, Introduction to Probability and Statistics should resolve a named weakness in causal inference rather than add undirected breadth for biostatistical analyst goals. Applicants bringing existing causal inference work can ask whether Introduction to Probability and Statistics deepens or merely repeats that preparation. The answer should be tested against the place of Introduction to Probability and Statistics in the final programme requirement and the biostatistical analyst portfolio. If that connection is thin, the real-world evidence researcher option deserves more attention than the biostatistical analyst route.

What does the Stanford MS Epidemiology and Clinical Research curriculum contain?

The official curriculum requires 45 credit hours. The table preserves every named coded item found on that page and keeps published curriculum areas where Stanford directs students to an approved list. Availability and prerequisites still need a live check before enrolment.

The note “Published curriculum item” applies to 4 components in this table.

• Complete 45 approved graduate credit hours.
• Follow the published choice among a faculty-supervised clinical research thesis or substantial project.
• Confirm approved electives, prerequisites and the plan of study with the academic unit.

Use the required sequence to establish readiness for Design and Conduct of Clinical and Epidemiologic Studies, then choose electives that deepen causal inference instead of creating several disconnected introductions. The official plan of study remains the authority for what can count together.

Stanford can revise course availability and approved lists. Recheck every code, credit value, campus offering and culminating route before accepting an offer, especially where the catalogue publishes an area rather than a closed list of named electives.

Should an Indian applicant shortlist the Stanford MS Epidemiology and Clinical Research?

Shortlist the Stanford MS Epidemiology and Clinical Research when your transcript already supports epidemiologic design and biostatistics, your intended work uses causal inference and the full INR 2.29 crore plan is fundable without depending on uncertain work income. Treat those as separate thresholds.

The strongest case connects Design and Conduct of Clinical and Epidemiologic Studies to Advanced Epidemiologic Methods, then uses the culminating route to create inspectable proof. That is a clearer reason to choose this degree than a general wish to study at a large US university.

Stanford does not publish a numeric entry GPA floor for this programme, but selection can still test subject depth and overall academic strength. The conservative cost case is INR 2.29 crore before flights and a housing deposit, and Stanford publishes no guaranteed job or sponsorship outcome for this exact programme.

Sources

These sources support the programme, admission, cost, experience and immigration information used on this page.

Sources checked on September 29, 2026. Current intake information follows. Autumn 2027 full-time on-campus.